Oceanside Pharma Technical Development, Genentech, Inc, Oceanside, California, USA.
Biotechnol Bioeng. 2012 Jul;109(7):1685-92. doi: 10.1002/bit.24450. Epub 2012 Feb 6.
NS0 cells require exogenous cholesterol for growth. The non-glutamine synthetase (GS) cholesterol-dependent NS0 host was treated with 5-azacytidine (5azaC), a demethylation drug, and adapted to grow in cholesterol-free, chemically defined medium. Within 7 weeks, a stable, cholesterol-independent NS0 host (NS0.CF) was obtained. The new NS0.CF host, as well as the original cholesterol auxotroph host, was transfected with the same mAb expression plasmid, and the top producing clone from both hosts were compared side-by-side in the enhanced platform fed-batch cultures using chemically defined media. The NS0.CF derived clone significantly out-performed the cholesterol-dependent clone, with titer reaching 4.5 g/L versus 3.0 g/L, respectively, mainly due to higher specific productivity, while key product quality attributes remained comparable. This work demonstrated an effective and rapid approach to generate a cholesterol-independent NS0 host, and its application in recombinant protein production.
NS0 细胞的生长需要外源性胆固醇。非谷氨酰胺合成酶(GS)胆固醇依赖性 NS0 宿主用 5-氮杂胞苷(5azaC)处理,5-氮杂胞苷是一种去甲基化药物,并适应在不含胆固醇的化学定义培养基中生长。在 7 周内,获得了一种稳定的、不依赖胆固醇的 NS0 宿主(NS0.CF)。用相同的单克隆抗体表达质粒转染新的 NS0.CF 宿主和原始的胆固醇营养缺陷型宿主,在使用化学定义培养基的强化平台分批补料培养中,将来自两个宿主的最高产克隆并排比较。NS0.CF 衍生的克隆显著优于依赖胆固醇的克隆,滴度分别达到 4.5 g/L 和 3.0 g/L,主要是由于更高的比生产率,而关键产品质量属性仍保持可比。这项工作展示了一种有效且快速的方法来生成不依赖胆固醇的 NS0 宿主,并将其应用于重组蛋白生产。